Company Overview
LIGAND PHARMACEUTICALS INC
LGNDRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
268M
2025 FY
Net Income
124M
2025 FY
Shares Outstanding
19M
2025 FY
EPS
6.44USD
2025 FY
Company Information
SIC Code
2834
CIK Code
886163
Exchange
Nasdaq
Location
US